TR199903240T2 - Agiz yoluyla proteinlerin verilmesi için yöntem - Google Patents

Agiz yoluyla proteinlerin verilmesi için yöntem

Info

Publication number
TR199903240T2
TR199903240T2 TR1999/03240T TR9903240T TR199903240T2 TR 199903240 T2 TR199903240 T2 TR 199903240T2 TR 1999/03240 T TR1999/03240 T TR 1999/03240T TR 9903240 T TR9903240 T TR 9903240T TR 199903240 T2 TR199903240 T2 TR 199903240T2
Authority
TR
Turkey
Prior art keywords
oral administration
proteins
hydrogel matrix
composition
bioactive
Prior art date
Application number
TR1999/03240T
Other languages
English (en)
Inventor
A. Peppas Nicholas
M. Lowman Anthony
Nagai Tsuneji
Morishita Mariko
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of TR199903240T2 publication Critical patent/TR199903240T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Bioaktif bilesenlerinin omurgalilara oral uygulanmasi için bir bilesim ve yöntem tarif edilmektedir. Bu yöntem bir büyüyebilen hidrojel matrisi ve bu hidrojel matris içinde yer alan bir bioaktif bilesimden olusan bir bilesimin omurgaliya oral olarak uygulanmasi adimindan olusur.
TR1999/03240T 1997-04-02 1998-04-02 Agiz yoluyla proteinlerin verilmesi için yöntem TR199903240T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4228097P 1997-04-02 1997-04-02
US6136797P 1997-10-08 1997-10-08

Publications (1)

Publication Number Publication Date
TR199903240T2 true TR199903240T2 (tr) 2000-05-22

Family

ID=26719055

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03240T TR199903240T2 (tr) 1997-04-02 1998-04-02 Agiz yoluyla proteinlerin verilmesi için yöntem

Country Status (14)

Country Link
EP (1) EP0975328A1 (tr)
JP (1) JP2002512607A (tr)
KR (1) KR20010005952A (tr)
CN (1) CN1259045A (tr)
AU (1) AU727053B2 (tr)
BR (1) BR9808466A (tr)
CA (1) CA2285457A1 (tr)
IL (1) IL132176A0 (tr)
NO (1) NO994757L (tr)
NZ (1) NZ500075A (tr)
PL (1) PL335974A1 (tr)
TR (1) TR199903240T2 (tr)
WO (1) WO1998043615A1 (tr)
YU (1) YU49699A (tr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
DE10040592A1 (de) * 2000-08-15 2002-03-07 Aventis Res & Tech Gmbh & Co Formulierung zur verbesserten Aufnahme von Wirkstoffen und deren Verwendung
US6878384B2 (en) 2001-03-13 2005-04-12 Microvention, Inc. Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
CA2479751C (en) 2002-03-20 2008-06-03 Trent Poole Inhalation apparatus
ES2385934T3 (es) 2004-08-20 2012-08-03 Mannkind Corporation Catálisis de la síntesis de dicetopiperazina.
KR101644250B1 (ko) 2004-08-23 2016-07-29 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
WO2006110448A2 (en) * 2005-04-07 2006-10-19 Drexel University Bioactive thermogelling polymer systems and methods of their use
CN101287443B (zh) 2005-07-29 2013-05-29 斯蒂茨廷格罗宁根药物研究中心 pH控制的脉冲释放系统、其制备方法和用途
CA2617226A1 (en) * 2005-08-01 2007-02-08 Mannkind Corporation Method of preserving the function of insulin-producing cells
DK1928423T3 (en) 2005-09-14 2016-02-29 Mannkind Corp A method for drug formulation based on increasing the affinity of the active substances to the crystalline microparticle surfaces
US8039431B2 (en) 2006-02-22 2011-10-18 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
KR101443926B1 (ko) 2006-06-15 2014-10-02 마이크로벤션, 인코포레이티드 팽창성 중합체로 제조된 색전술용 장치
EP2231215B1 (en) 2007-12-21 2019-01-30 MicroVention, Inc. Hydrogel filaments for biomedical uses
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
AU2009257311B2 (en) 2008-06-13 2014-12-04 Mannkind Corporation A dry powder inhaler and system for drug delivery
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
JP5667095B2 (ja) 2009-03-11 2015-02-12 マンカインド コーポレイション 吸入器の抵抗を測定するための装置、システムおよび方法
CA2764505C (en) 2009-06-12 2018-09-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
HUP0900482A2 (en) 2009-08-03 2011-03-28 Cera Med Kft Pharmaceutical formulation for oral administration
CN102665606A (zh) 2009-09-24 2012-09-12 微排放器公司 用于生物医学用途的可注射水凝胶线丝
US9993252B2 (en) 2009-10-26 2018-06-12 Microvention, Inc. Embolization device constructed from expansile polymer
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
RU2571331C1 (ru) 2010-06-21 2015-12-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
CN105667994B (zh) 2011-04-01 2018-04-06 曼金德公司 用于药物药盒的泡罩包装
WO2012145431A2 (en) 2011-04-18 2012-10-26 Microvention, Inc. Embolic devices
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
CA2852536A1 (en) 2011-10-24 2013-05-02 Mannkind Corporation Methods and compositions for treating pain
WO2013158781A1 (en) 2012-04-18 2013-10-24 Microvention, Inc. Embolic devices
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
ES2754388T3 (es) 2013-03-15 2020-04-17 Mannkind Corp Composiciones y métodos de dicetopiperazina microcristalina
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
WO2015021044A1 (en) * 2013-08-05 2015-02-12 University Of Rochester Compositions and methods for stimuli-responsive release of a therapeutic agent
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10124090B2 (en) 2014-04-03 2018-11-13 Terumo Corporation Embolic devices
WO2015167752A1 (en) 2014-04-29 2015-11-05 Microvention, Inc. Polymers including active agents
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10265405B2 (en) 2014-11-18 2019-04-23 Board Of Regents, The University Of Texas System Polymers for delivery of factor VIII and/or factor IX
WO2016201250A1 (en) 2015-06-11 2016-12-15 Microvention, Inc. Expansile device for implantation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976576A (en) * 1956-04-24 1961-03-28 Wichterle Otto Process for producing shaped articles from three-dimensional hydrophilic high polymers
US3220960A (en) * 1960-12-21 1965-11-30 Wichterle Otto Cross-linked hydrophilic polymers and articles made therefrom
DE1617393C2 (de) * 1966-01-06 1982-11-11 Československá akademie věd, Praha Verfahren zur Herstellung von biologisch aktive Stoffe enthaltenden hydrophilen vernetzten Copolymeren
US3607848A (en) * 1967-08-07 1971-09-21 Ceskoslovenska Akademie Ved Method for preparing insoluble,cross-linked organic hydrogels comprising copolymers of glycol monoesters with diesters
US3885078A (en) * 1968-03-06 1975-05-20 Ceskoslovenska Akademie Ved Hydrogel laminates and method of manufacturing thereof
US4071508A (en) * 1975-02-11 1978-01-31 Plastomedical Sciences, Inc. Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates
FR2601026B1 (fr) * 1986-04-15 1988-09-16 Rhone Poulenc Chimie Matiere seche hydratable en un gel aqueux contenant des particules de polymeres dispersees, procede pour sa preparation et son application en biologie

Also Published As

Publication number Publication date
CA2285457A1 (en) 1998-10-08
AU727053B2 (en) 2000-11-30
NZ500075A (en) 2001-03-30
JP2002512607A (ja) 2002-04-23
EP0975328A1 (en) 2000-02-02
BR9808466A (pt) 2001-08-07
IL132176A0 (en) 2001-03-19
YU49699A (sh) 2002-12-10
AU6880998A (en) 1998-10-22
PL335974A1 (en) 2000-06-05
NO994757L (no) 1999-11-29
NO994757D0 (no) 1999-09-30
CN1259045A (zh) 2000-07-05
KR20010005952A (ko) 2001-01-15
WO1998043615A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
TR199903240T2 (tr) Agiz yoluyla proteinlerin verilmesi için yöntem
IT1232827B (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
ATE103932T1 (de) Fusionsprotein bestehend aus gm-csf und il-3.
LV11279A (lv) Farmaceitiska kompozicija kas satur nervu augsanas faktoru
ES2088006T3 (es) Composiciones farmaceuticas osteoinductivas.
FI961037A (fi) Valmisteet osteogenisten proteiinien antamiseksi
DE69430990D1 (de) Zusammensetzung und methode zur anreicherung von weissen blutzellen aus menschlichem vollblut
DK1629849T3 (da) Farmaceutiske sammensætninger indeholdende exendiner og deres agonister
ID27936A (id) Metode dan komposisi ekspresi transgen pada tanaman
DE69632859D1 (de) Verfahren zur wirkstoffbeladung von lipsomen und zusammensetzung
DK0785948T3 (da) Analoger af keratinocyt vækstfaktor
EE9800425A (et) Uued aminohappe derivaadid ja nende kasutamine trombiini inhibiitoritena
ES2148593T3 (es) Compuestos retinoides trienoicos novedosos y metodos.
DE69522188T2 (de) Verwendung von Substanz P Antagonist im pharmazeutischer Zusammensetzung
FR2763949B1 (fr) Compose stabilisant, composition le contenant et procede l'utilisant
PT1244472E (pt) Composicao vitaminica em particulas
HUP9900506A2 (hu) Protrombinszármazékok
NO20000425D0 (no) Collagen type I og type III klebende sammensetninger
DE69732616D1 (de) Erhöhung der Migration oder Proliferation von Keratinocyten
MX169334B (es) Preparacion de liberacion sostenida
DK64588A (da) Sammensat materiale og kunstig agn
DE69528473D1 (de) Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen
FR2635008B1 (fr) Agent activateur de la productivite specifique des cellules animales recombinantes a base de polyvinylpyrrolidone et milieu de culture defini le contenant
DK0915655T3 (da) Fremgangsmåde og sammensætning til behandling mod parasitter i dyrs omgivelser
DE69829953D1 (de) Kristallisation von proteinen